PURPOSE: The objective of this study was to use a nonhuman primate model to examine the effects of growth hormone (GH) on oocyte in vitro maturation (IVM). METHODS: Immunocytochemistry confirmed the presence of GH receptors in rhesus cumulus oocyte complexes and the cytoplasm of embryonic blastomeres. Recombinant human GH (r-hGH) was added to IVM medium and cumulus expansion, nuclear maturation, cytoplasmic maturation and embryo development were analyzed. RESULTS: Cumulus expansion was highest in the presence of 1 and 10 ng/ml r-hGH. The addition of r-hGH during IVM increased the percentage of embryos progressing to at least the 9-16 cell stage. In a separate study, 100 ng/ml r-hGH was supplemented to IVM and embryo culture medium and no effect was observed. CONCLUSIONS: The presence of GH receptors along with increased cumulus expansion and embryos progressing to the 9-16 cell stage supports the hypothesis that r-hGH may be involved in oocyte maturation.
PURPOSE: The objective of this study was to use a nonhuman primate model to examine the effects of growth hormone (GH) on oocyte in vitro maturation (IVM). METHODS: Immunocytochemistry confirmed the presence of GH receptors in rhesus cumulus oocyte complexes and the cytoplasm of embryonic blastomeres. Recombinant human GH (r-hGH) was added to IVM medium and cumulus expansion, nuclear maturation, cytoplasmic maturation and embryo development were analyzed. RESULTS: Cumulus expansion was highest in the presence of 1 and 10 ng/ml r-hGH. The addition of r-hGH during IVM increased the percentage of embryos progressing to at least the 9-16 cell stage. In a separate study, 100 ng/ml r-hGH was supplemented to IVM and embryo culture medium and no effect was observed. CONCLUSIONS: The presence of GH receptors along with increased cumulus expansion and embryos progressing to the 9-16 cell stage supports the hypothesis that r-hGH may be involved in oocyte maturation.
Authors: A Kidson; F J Rubio-Pomar; A Van Knegsel; H T A Van Tol; W Hazeleger; D W B Ducro-Steverink; B Colenbrander; S J Dieleman; M M Bevers Journal: Reproduction Date: 2004-02 Impact factor: 3.906
Authors: Namdori R Mtango; Miriam Sutovsky; Catherine A Vandevoort; Keith E Latham; Peter Sutovsky Journal: J Cell Physiol Date: 2012-05 Impact factor: 6.384
Authors: Jenna K Nyholt de Prada; Young S Lee; Keith E Latham; Charles L Chaffin; Catherine A VandeVoort Journal: Am J Physiol Endocrinol Metab Date: 2009-03-10 Impact factor: 4.310
Authors: Uros Midic; Pei-Hsuan Hung; Kailey A Vincent; Benjamin Goheen; Patrick G Schupp; Diane D Chen; Daniel E Bauer; Catherine A VandeVoort; Keith E Latham Journal: Hum Mol Genet Date: 2017-07-15 Impact factor: 6.150
Authors: Peter Z Schall; Meghan L Ruebel; Uros Midic; Catherine A VandeVoort; Keith E Latham Journal: Mol Hum Reprod Date: 2019-03-01 Impact factor: 4.025